Results 151 to 160 of about 286,717 (340)

A Clinicopathological Study of 24 Cases of DFSP

Journal of Plastic and Reconstructive Surgery
Objectives: Dermatofibrosarcoma protuberans (DFSP) usually arises in the dermis and spreads to the underlying subcutaneous tissue (cutaneous DFSP). However, it rarely appears in the subcutaneous tissue (subcutaneous DFSP).
Miyako Kachi, Atsumori Hamahata, Kohei Oashi, Hisato Konoeda, Miho Kirita, Masashi Ishikawa, Hirotaka Koyanagi, Hiroyuki Sakurai   +7 more
doaj  

Expression of Transcription Factors during Megakaryocytic Differentiation of CD34+ Cells from Human Cord Blood Induced by Thrombopoietin

, 2000
Kiminori Terui, Yoshihiro Takahashi, Junichi Kitazawa, Tsutomu Toki, Masaru Yokoyama, Etsuro Ito   +5 more
openalex   +2 more sources

circNR3C2 promotes chondrogenic differentiation and cartilage repair of human adipose‐derived stem cells via the hsa‐miR‐647/SOX9 pathway

Animal Models and Experimental Medicine, EarlyView.
The hypothesis diagram illustrates the function and mechanism of circNR3C2: circNR3C2 overexpression can up‐regulate COL2, Aggrecan and SOX9 expression, and regulate chondrogenic differentiation of hADSCs by targeting hsa‐miR‐647. Abstract Background Human adipose‐derived stem cells (hADSCs) are seed cells with application prospects in cartilage repair.
Dabiao Hou, Huajun Wang, Hao Guo, Dongbin Luo, Xiaofei Zheng, Simin Luo   +5 more
wiley   +1 more source

Superficial CD34 Positive Fibroblastic Tumor: A rare mesenchymal tumor of borderline malignant potential.

Journal of Pathology of Nepal
Superficial CD34 positive fibroblastic tumor is a rare soft tissue tumor first brought to light by Jodi M Carter in 2014. Several cases have been reported since, and they have been newly included in the recent WHO classification under the fibroblastic ...
Pradnya Kamble, Jayashree Chaudhari, Manisha Khare   +2 more
doaj   +1 more source

Isolation and molecular characterization of the human CD34 gene [PDF]

, 1992
He Xy, VP Antao, D Basila, JC Marx, BR Davis   +4 more
openalex   +1 more source

Baseline Factors Identified For Prediction of Good Responders in Patients With End-Stage Diffuse Coronary Artery Disease Undergoing Intracoronary CD34+ Cell Therapy [PDF]

, 2020
Pei‐Hsun Sung, Hsin‐Ju Chiang, Yi‐Chen Li, John Y.L. Chiang, Chi‐Hsiang Chu, Pei‐Lin Shao, Fan-Yen Lee, Mel S. Lee, Hon‐Kan Yip   +8 more
openalex   +1 more source

Monocyte‐Derived Macrophages‐Synovial Fibroblasts Crosstalk Unravels Oncostatin Signaling Network as a Driver of Synovitis in Osteoarthritis

Arthritis &Rheumatology, EarlyView.
Objective Osteoarthritis (OA) is a debilitating joint disease that is characterized by cartilage degradation, synovial inflammation, and pain. Macrophages have been implicated in OA pathology, but the origins and functions of diverse macrophage subsets seeding the synovial joint tissue remain incompletely understood.
Damien Laouteouet, Olivier Bortolotti, Léa Marineche, Nicole Hannemann, Manon Chambon, Yaël Glasson, Anne‐Sophie Dumé, Julien De Lima, Maud Fournial, Dylan Touchet, Dany Séverac, Felicia Leccia, Christophe Duperray, Henri‐Alexandre Michaud, Farida Djouad, Benoît Le Goff, Frédéric Blanchard, Florence Apparailly, Gabriel Courties   +18 more
wiley   +1 more source

Nuclear entrapment of BCR–ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells

, 2009
Elaine Allan, Ashley Hamilton, Sophia Hatziieremia, Peixun Zhou, Heather G. Jørgensen, Paolo Vigneri, Tessa L. Holyoake   +6 more
openalex   +2 more sources

Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34⁺ Cells from Atherosclerotic Patients with Type 2 Diabetes [PDF]

, 2016
Sylvie Cointe, Éric Rhéaume, Catherine Martel, Olivier Blanc‐Brude, Évemie Dubé, Florence Sabatier, Françoise Dignat‐George, Jean‐Claude Tardif, Arnaud Bonnefoy   +8 more
openalex   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source